Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Sacubitril/valsartan

Hyperkalaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Rigueira J, et al. Neurohormonal antagonist therapies, renal function and kalaemia: A trade-off to consider when treating heart failure patients. European Journal of Heart Failure 21 (Suppl. 1): 205 abstr. P909, May 2019. Available from: URL: http://doi.org/10.1002/ejhf.1488 [abstract] - Portugal Rigueira J, et al. Neurohormonal antagonist therapies, renal function and kalaemia: A trade-off to consider when treating heart failure patients. European Journal of Heart Failure 21 (Suppl. 1): 205 abstr. P909, May 2019. Available from: URL: http://​doi.​org/​10.​1002/​ejhf.​1488 [abstract] - Portugal
Metadaten
Titel
Sacubitril/valsartan
Hyperkalaemia: case report
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-66047-7

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Heparin

Case report

Penicillamine

Case report

Alteplase

Case report

Doxycycline